Diseases, Conditions, Syndromes

Mpox vaccine maker seeks approval for use in teens

Danish drugmaker Bavarian Nordic said Friday it was seeking European approval to use its mpox vaccine in children aged 12 to 17, after the WHO declared the current virus surge a global public health emergency.

Diseases, Conditions, Syndromes

Exploring how poxviruses dismantle antiviral responses

Northwestern Medicine investigators led by Derek Walsh, Ph.D., professor of Microbiology-Immunology, have discovered how poxviruses disarm and evade mitochondrial-driven antiviral responses for their replication in host cells, ...

Diseases, Conditions, Syndromes

Investigating the smallpox blanket controversy

In Indian Country, it is an accepted fact that white settlers distributed items, such as blankets contaminated with smallpox and other infectious diseases, aiming to reduce the population of Native people resisting their ...

Diseases, Conditions, Syndromes

Evaluating equine immunoglobulin F(ab′) 2 for treatment of smallpox

Smallpox, a severe infectious disease caused by the smallpox virus, causes a death rate as high as 30% within 15–20 days after infection. Therefore, development of an anti-smallpox product as a strategic reserve is urgently ...

page 1 from 8